Editorial comment: Triple infection with HIV and hepatitis B and C viruses - Lesson in combination therapy

AIDS Reader

Volumn 14, Issue 7, 2004, Pages 392-

  Dore, Gregory J ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; PEGINTERFERON; RIBAVIRIN; VIRUS DNA; VIRUS RNA;

DRUG EFFICACY; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER TOXICITY; LYMPHOCYTE COUNT; NOTE; SUPERINFECTION;

ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS;

EID: 3242692271     PISSN: 10530894     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (8)

1. Dore GJ, Cooper DA. The impact of HIV therapy on co-infection with hepatitis B and hepatitis C viruses. Curr Opin Infect Dis. 2001;14:749-755.
2. Sterling RK. Triple infection with human immunodeficiency virus, hepatitis C virus, and hepatitis B virus: a clinical challenge. Am J Gastroenterol. 2003;98: 2130-2134.
3. Johanson F. Tri-infection: successful treatment of a patient infected with HIV and hepatitis B and C viruses - a case report. AIDS Reader. 2004;14:389-394.
4. Di Martino V, Thevenot T, Colin JF, et al. Influence of HIV infection on the response to interferon therapy and the long-term outcome of chronic hepatitis B. Gastroenterology. 2002;123:1812-1822.
5. Mohsen AH, Easterbrook P, Taylor CB, Norris S. Hepatitis C and HIV-1 coinfection. Gut. 2002;51:601-608.
6. Liu CJ, Chen PJ, Lai MY, et al. Ribavirin and interferon is effective for hepatitis C virus clearance in hepatitis B and C dually infected patients. Hepatology. 2003;37:568-576.
7. Villa E, Grottola A, Buttafoco P, et al. High doses of alpha-interferon are required in chronic hepatitis due to coinfection with hepatitis B virus and hepatitis C virus: long term results of a prospective randomized trial. Am J Gastroenterol. 2001;96:2973-2977.
8. Marcellin P, Lau GKK, Bonino F, et al. Peginterferon alfa-2a (40KD) (PEGASYS) monotherapy is more effective than lamivudine monotherapy in the treatment of HBeAg-negative chronic hepatitis B: 72-week results from a phase III, partially double-blind study of Pegasys alone vs Pegasys plus lamivudine vs lamivudine. J Hepatol. 2004;40(suppl 1):34. Abstract 95.